[Use of the right gastroepiploic artery graft in revascularization of the myocardium].
The right gastroepiploic artery (rGEA) was used as a graft for revascularization of the heart muscle in 239 patients along with other arterial grafts obtained from the internal mammary arteries (IMA). The mean follow-up of patients after operation was 17 months, the longest period being 38 months with a total follow-up period of 4,063 months. The authors recorded a high percentage of patency of the graft during check-up catheterization after a 6-month interval (94.7%), a low incidence of early complications of minor importance (2.5%), a low percentage of anginose complaints (7.9%) and reoperations (5%), while the lethality was not higher than in the control group (2.51%). The use of a graft from the rGEA is very suited for surgical treatment of IHD, in particular in patients of younger age groups and in reoperations. The authors discuss contraindications, the majority being only relative contraindications. The authors deal also with the preparatory surgical technique and the use of the graft.
Hájek
T
T
Thoraxcentrum, Academisch Ziekenhuis Groningen, Holland.
Eijgelaar
A
A
D003327:Coronary Disease / Q000601:surgery; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*; D013270:Stomach / Q000098:blood supply
Vyuzití stĕpu pravé gastroepiploické artérie pri revaskularizaci myokardu.